Reinitiating obesity meds after bariatric surgery tied to greater one-year weight loss in youths
Restarting obesity medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, soon after sleeve gastrectomy (SG) is associated with greater one-year weight loss than surgery alone in adolescents, according to a research letter published online July 22 in JAMA Surgery.
Source: Medical Xpress
